Venture Visionary Partners LLC Moderna, Inc. Transaction History

Venture Visionary Partners LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 14, 2023	SELL	$118.5 - $160.53 $3,199 - $4,334	-27 Reduced 0.28%	9,649 $1.17 Million
Q1 2023 Apr 13, 2023	SELL	$135.66 - $197.02 $110,562 - $160,571	-815 Reduced 7.77%	9,676 $1.49 Million
Q4 2022 Feb 09, 2023	SELL	$118.38 - $210.04 $54,454 - $96,618	-460 Reduced 4.2%	10,491 $1.88 Million
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $528,363 - $868,955	4,475 Added 69.1%	10,951 $1.29 Million
Q2 2022 Jul 26, 2022	BUY	$117.13 - $176.59 $542,897 - $818,494	4,635 Added 251.77%	6,476 $925,000
Q1 2022 May 03, 2022	BUY	$126.46 - $235.05 $15,807 - $29,381	125 Added 7.28%	1,841 $317,000
Q4 2021 Feb 08, 2022	SELL	$225.82 - $368.51 $30,259 - $49,380	-134 Reduced 7.24%	1,716 $435,000
Q3 2021 Oct 20, 2021	SELL	$221.9 - $484.47 $283,810 - $619,637	-1,279 Reduced 40.88%	1,850 $711,000
Q2 2021 Aug 05, 2021	BUY	$129.91 - $234.98 $63,006 - $113,965	485 Added 18.34%	3,129 $735,000
Q1 2021 Apr 27, 2021	BUY	$109.18 - $185.98 $288,671 - $491,731	2,644 New	2,644 $346,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Venture Visionary Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Venture Visionary Partners LLC with notifications on news.